Further multivariate analysis demonstrated that high DPYSL2 expression in AML was an independent marker of poor prognosis for OS (p = 0.027), EFS (p = 0.040), and RFS (p = 0.050) (Table 2). Here, DPYSL2 is linked to acute myeloid leukemia.